Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
MedTech
Adagio Medical implements strategic review, halves staff
Adagio Medical has initiated a strategic review and will lay off more than half its workers as it faces delisting on the Nasdaq exchange.
Joseph Keenan
Sep 24, 2026 7:59am
JATT mastermind launches latest biotech-focused SPAC in $60M IPO
Aug 26, 2026 9:45am
Hemab CEO seeks ‘flavor of a multi-product coagulation company’
Aug 13, 2026 9:00am
BlossomHill, Latigo outshine IPO expectations
Aug 7, 2026 11:10am
Treeline sees path to public markets via reverse merger
Jun 8, 2026 10:37am
Newly minted MiniMed nets CE mark for 780G pump, Instinct CGM
Mar 11, 2026 10:05am
